allicin has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czernizer, E; Dardik, A; Dardik, H; Hoffmann, T; London, D; Naftalovich, R; Orozco-Sevilla, V; Yang, C | 1 |
| Bradley, JM; Lefer, DJ; Organ, CL | 1 |
1 review(s) available for allicin and cardiovascular agents
| Article | Year |
|---|---|
Garlic-Derived Organic Polysulfides and Myocardial Protection.
Topics: Cardiovascular Agents; Disulfides; Garlic; Heart; Humans; Hydrogen Sulfide; Myocardium; Phytotherapy; Plant Extracts; Sulfides; Sulfinic Acids | 2016 |
1 other study(ies) available for allicin and cardiovascular agents
| Article | Year |
|---|---|
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.
Topics: Animals; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Intima-Media Thickness; Catechin; Cell Proliferation; Disease Models, Animal; Disulfides; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Injections, Intraperitoneal; Isothiocyanates; Male; Neointima; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfinic Acids; Sulfoxides; Time Factors | 2013 |